🦠 Evidence-Based Probiotics & Prebiotics Research Database: Strain Comparisons, CFU Dosing & Protocols
A curated, open-source research database for probiotics, prebiotics, and synbiotics — covering strain-by-condition comparisons, CFU dosing tiers, delivery system analysis, prebiotic fiber types with food sources, and quality assessment protocols. Every recommendation is backed by peer-reviewed research from PubMed, Cochrane, and NIH.
Your gut microbiome isn’t just about digestion. It’s a 3-5 pound ecosystem of bacteria, fungi, and viruses that communicates directly with your brain via the vagus nerve, trains 70% of your immune cells, produces 90% of your serotonin, and influences everything from your body weight to your skin clarity.
The problem is that modern life systematically destroys this ecosystem. Antibiotics, processed foods, chronic stress, and environmental toxins reduce microbial diversity — and reduced diversity is consistently linked to disease in clinical research [1]. Probiotics and prebiotics are the two primary tools for restoration, but navigating which strains, doses, and delivery systems actually work requires sifting through thousands of studies.
This database does that work for you. For the complete deep-dive on supplement recommendations and product reviews, see the HealthSecrets probiotic and prebiotic guide.
📋 Table of Contents
- Probiotic Strains Database
- CFU Dosing Guide
- Delivery Systems Comparison
- Prebiotic Types & Food Sources
- Synbiotic Research
- Quality Factors Checklist
- When to Use Probiotics & Prebiotics
- Side Effects & Contraindications
- Combining with Fermented Foods
- Curated Research Library
- Frequently Asked Questions
- 📋 Free Tools
- Contributing
- Disclaimer
- References
- Further Reading
Probiotic Strains Database
Not all probiotics are equal. A 2019 review in The Lancet Gastroenterology & Hepatology emphasized that probiotic effects are strain-specific — benefits proven for one strain cannot be assumed for another, even within the same species [8]. This database maps specific strains to the conditions they’ve been clinically validated for.
Strain-by-Condition Comparison Table
| Strain | Primary Conditions | Key Evidence | CFU Range | Evidence Grade |
|---|---|---|---|---|
| L. rhamnosus GG | Diarrhea, immune function, eczema (children) | 60% diarrhea reduction; 30% fewer infections; 50% eczema improvement in children | 10-20B | A |
| L. plantarum 299v | IBS, inflammation, gut barrier | 40% IBS symptom improvement; strengthens tight junctions | 10-20B | A |
| L. acidophilus NCFM | Vaginal health, general digestive support | 50% UTI reduction; vaginal microbiome restoration | 5-10B | B |
| L. reuteri DSM 17938 | Colic (infants), oral health, immune function | Reduced infant crying time by 50%; improved oral microbiome | 5-10B | A |
| B. longum 35624 | Anxiety, stress, IBS, inflammation | 50% anxiety reduction; reduced inflammatory markers | 10-20B | A |
| B. lactis BB-12 | Immune function, constipation (elderly), digestive health | 30% fewer respiratory/GI infections; improved bowel frequency | 10-20B | A |
| B. infantis 35624 | IBS (especially IBS-D), inflammation | Significant IBS-D improvement; normalized IL-10/IL-12 ratio | 10B | A |
| S. boulardii CNCM I-745 | Antibiotic-associated diarrhea, traveler’s diarrhea, C. difficile | 70% AAD prevention; 50% C. difficile recurrence reduction | 5-10B | A |
| B. coagulans GBI-30, 6086 | IBS, digestive comfort, immune support | Improved IBS symptoms; spore-forming (survives stomach acid) | 1-2B | B |
| L. casei Shirota | Immune function, digestive health, mood | Reduced upper respiratory infections; improved mood scores | 10-20B | B |
Evidence Grades: A = Multiple RCTs or meta-analyses confirming efficacy. B = At least 1-2 well-designed RCTs. C = Preliminary evidence (animal studies, small human trials).
Lactobacillus Species — Detailed Profiles
L. rhamnosus GG (LGG) — The most studied probiotic strain in the world, with over 1,000 published studies. A 2019 Cochrane review confirmed it reduces acute infectious diarrhea duration by approximately 1 day and prevents 60% of antibiotic-associated diarrhea cases [2]. In children, a 2018 meta-analysis found LGG reduced eczema incidence by 50% when given to mothers during late pregnancy and to infants during the first 6 months [9]. Dosing: 10-20 billion CFU daily.
L. plantarum 299v — The go-to strain for IBS. A 2018 RCT published in World Journal of Gastroenterology found 40% improvement in IBS symptom severity scores after 4 weeks at 10 billion CFU daily [10]. The mechanism is gut barrier reinforcement — L. plantarum strengthens tight junctions between intestinal cells, reducing intestinal permeability (“leaky gut”) and downstream inflammation.
L. acidophilus NCFM — Primarily studied for vaginal and urogenital health. A 2013 systematic review found L. acidophilus reduced recurrent UTI incidence by approximately 50% in women, with additional evidence supporting prevention of bacterial vaginosis and yeast infections [11]. Dosing: 5-10 billion CFU daily.
Bifidobacterium Species — Detailed Profiles
B. longum 35624 — The most compelling evidence for the gut-brain axis. A 2017 randomized controlled trial in Translational Psychiatry found 50% reduction in anxiety scores and measurable stress hormone improvements after 8 weeks of supplementation [3]. Also effective for IBS, with significant improvements in bloating and pain scores. Dosing: 10-20 billion CFU daily for 8-12 weeks (mental health benefits require sustained use).
B. lactis BB-12 — The immune workhorse. A 2014 meta-analysis found B. lactis reduced respiratory and GI infections by 30% in both children and adults [12]. Particularly effective in elderly populations, where it also improved constipation by increasing bowel frequency. Dosing: 10-20 billion CFU daily.
Saccharomyces boulardii — Yeast Probiotic
S. boulardii CNCM I-745 is unique — it’s a beneficial yeast, not a bacterium. This matters because antibiotics don’t kill it. A 2015 meta-analysis of 21 RCTs found S. boulardii prevented antibiotic-associated diarrhea in 70% of cases and reduced C. difficile recurrence by 50% when used alongside standard antibiotic treatment [4]. It’s the only probiotic you can take simultaneously with antibiotics without timing separation. Dosing: 250-500 mg (equivalent to 5-10 billion CFU) twice daily.
CFU Dosing Guide
CFU (Colony Forming Units) measures the number of viable, live microorganisms in a probiotic dose. Higher isn’t always better — a 2020 review in Nutrients found that strain specificity, delivery system, and viability at expiration matter significantly more than raw CFU count [5].
CFU Dosing Tiers
| Tier | CFU Range | Purpose | When to Use | Duration |
|---|---|---|---|---|
| Maintenance | 1-10 billion | Daily gut health, general wellness | Ongoing daily supplementation | Indefinite |
| Therapeutic | 10-50 billion | IBS, post-antibiotic recovery, immune support, mental health | Active health concerns | 8-12 weeks, then reassess |
| Intensive | 50-100+ billion | Severe dysbiosis, C. difficile, post-infection recovery | Under clinical guidance | 4-8 weeks, then step down |
Condition-Specific Dosing Protocols
| Condition | Recommended Strain(s) | CFU Dose | Duration | Key Evidence |
|---|---|---|---|---|
| General maintenance | Multi-strain (5-15 species) | 10-20B daily | Ongoing | Mimics healthy diversity |
| IBS / digestive issues | L. plantarum 299v, B. infantis 35624 | 10-50B daily | 8-12 weeks | 40% symptom improvement [10] |
| During antibiotics | S. boulardii | 5-10B twice daily | During + 2 weeks after | 70% AAD prevention [4] |
| Post-antibiotic restoration | Multi-strain + S. boulardii | 20-50B daily | 2-4 weeks after course | Microbiome recovery |
| Anxiety / depression | B. longum 35624 | 10-20B daily | 8-12 weeks minimum | 50% anxiety reduction [3] |
| Immune support | L. rhamnosus GG, B. lactis BB-12 | 10-20B daily | Seasonal or ongoing | 30% fewer infections [12] |
| Traveler’s diarrhea prevention | S. boulardii, L. rhamnosus GG | 10-20B daily | 1 week before → during → 1 week after | Preventive |
| Eczema (children) | L. rhamnosus GG | 10B daily | 3-6 months | 50% reduction [9] |
| Vaginal health | L. acidophilus, L. rhamnosus, L. reuteri | 5-10B daily | 4-8 weeks | 50% UTI reduction [11] |
| Constipation (elderly) | B. lactis BB-12, B. longum | 10-20B daily | 4-8 weeks | Improved bowel frequency [12] |
Important: Start at the lower end of the range and increase over 1-2 weeks. Initial GI symptoms (mild bloating, gas) typically resolve within the first week as the microbiome adjusts.
Delivery Systems Comparison
How a probiotic is delivered matters as much as which strain you choose. Stomach acid destroys 90-99% of unprotected bacteria before they reach the colon, where they need to colonize [13]. The delivery system determines how many organisms actually survive transit.
| Delivery System | Acid Survival | Shelf Stability | Convenience | Best For | Cost |
|---|---|---|---|---|---|
| Enteric-coated capsules | ⭐⭐⭐⭐⭐ 10x better | ⭐⭐⭐⭐ Good | ⭐⭐⭐⭐ Easy | Maximum delivery to colon | $$$ |
| Delayed-release capsules | ⭐⭐⭐⭐ Very good | ⭐⭐⭐⭐ Good | ⭐⭐⭐⭐ Easy | Time-released colonization | $$$ |
| Spore-forming (Bacillus) | ⭐⭐⭐⭐⭐ Natural | ⭐⭐⭐⭐⭐ Excellent | ⭐⭐⭐⭐⭐ No refrigeration | Travel, heat resistance | $$ |
| Shelf-stable (freeze-dried) | ⭐⭐⭐ Moderate | ⭐⭐⭐⭐⭐ Excellent | ⭐⭐⭐⭐⭐ Room temp storage | Travel, convenience | $$ |
| Refrigerated (live cultures) | ⭐⭐⭐ Moderate | ⭐⭐ Requires cold chain | ⭐⭐ Needs refrigeration | Maximum initial potency | $$$ |
| Standard capsules | ⭐ Poor (90-99% destroyed) | ⭐⭐⭐ Variable | ⭐⭐⭐⭐ Easy | Budget option (less effective) | $ |
| Powder/sachets | ⭐⭐ Poor-moderate | ⭐⭐⭐ Variable | ⭐⭐⭐ Mixable | Children, dose flexibility | $$ |
Delivery Selection Guide
For maximum therapeutic effect → Enteric-coated or delayed-release capsules. These protect bacteria through the stomach (pH 1.5-3.5) and release them in the small intestine and colon (pH 6.0-7.4). A 2019 in vitro study found enteric-coated capsules delivered 10x more viable organisms to the colon than standard capsules [13].
For travel and convenience → Spore-forming probiotics (Bacillus coagulans, B. subtilis). Bacterial spores are nature’s survival pods — heat-stable, acid-resistant, and shelf-stable at room temperature for years. No refrigeration needed. B. coagulans GBI-30, 6086 has clinical evidence for IBS and immune support [14].
For daily maintenance → Shelf-stable freeze-dried capsules offer a practical balance of viability and convenience. Modern lyophilization (freeze-drying) technology maintains 80-90% viability at room temperature for 18-24 months.
For children → Powder or sachet formats that can be mixed into food or drinks. This allows flexible dosing and avoids swallowing capsules.
Prebiotic Types & Food Sources
Prebiotics are non-digestible fibers that selectively feed beneficial gut bacteria, increasing Bifidobacterium and Lactobacillus populations by up to 100-fold within 2-4 weeks. A 2025 systematic review of 22 RCTs confirmed that prebiotic supplementation consistently increased beneficial bacteria abundance and short-chain fatty acid (SCFA) production across diverse populations [6].
Prebiotic Fiber Types Comparison
| Prebiotic Type | Primary Sources | Recommended Dose | Key Actions | Fermentation Products |
|---|---|---|---|---|
| Inulin | Chicory root, Jerusalem artichoke, garlic, onions | 5-10g/day | Bifidogenic; produces butyrate | Butyrate, acetate, propionate |
| FOS (Fructooligosaccharides) | Onions, garlic, asparagus, bananas | 5-10g/day | Selectively feeds Bifidobacterium (10-100x increase) | Butyrate, acetate |
| GOS (Galactooligosaccharides) | Legumes, dairy (small amounts), human breast milk | 5-10g/day | Strongly bifidogenic; similar to breast milk oligosaccharides | Acetate, lactate |
| Resistant starch | Cooked & cooled potatoes/rice/pasta, green bananas, oats | 10-20g/day | Major butyrate producer; anti-inflammatory | Butyrate (primary) |
| Pectin | Apples, citrus fruits, berries | 5-10g/day | Soluble fiber; regulates blood sugar | Acetate, propionate |
| Beta-glucan | Oats, barley, mushrooms | 3-5g/day | Immune modulation; cholesterol reduction | Mixed SCFAs |
Prebiotic Food Sources Database
| Food | Prebiotic Type | Content (g per serving) | Serving Size | Inulin/FOS % by Weight |
|---|---|---|---|---|
| Chicory root (raw) | Inulin | 11.8 | 1/2 cup (45g) | 64% |
| Jerusalem artichoke | Inulin | 9.4-18.8 | 1/2 cup (75g) | 31-47% |
| Garlic | Inulin/FOS | 0.5-1.6 | 3 cloves (9g) | 9-16% |
| Onion (raw) | FOS | 1.5-3.0 | 1 medium (150g) | 5-8% |
| Leeks | Inulin | 1.0-5.0 | 1 medium (89g) | 3-10% |
| Asparagus | Inulin/FOS | 0.5-0.7 | 4 spears (60g) | 2-3% |
| Banana (slightly green) | FOS/resistant starch | 0.5-1.0 | 1 medium (118g) | 0.5-1% |
| Oats | Beta-glucan/resistant starch | 1.5-2.5 | 1/2 cup dry (40g) | 3-4% |
| Apples | Pectin | 1.0-1.5 | 1 medium (182g) | 1-1.5% |
| Flaxseed | Soluble fiber | 4.0 | 2 tbsp (20g) | 20% |
| Barley | Beta-glucan | 2.5-3.0 | 1/2 cup cooked (79g) | 5-7% |
| Dandelion greens | Inulin | 1.5-2.0 | 1 cup raw (55g) | 12-15% |
| Cooked & cooled potatoes | Resistant starch | 3.0-5.0 | 1 medium (150g) | 2-3% |
| Green banana flour | Resistant starch | 10-12 | 2 tbsp (30g) | 40% |
4-Week Prebiotic Introduction Protocol
Rushing prebiotic intake causes bloating, gas, and GI discomfort. A gradual approach prevents this:
| Week | Daily Target | Strategy | Expected Adjustment |
|---|---|---|---|
| 1 | 5g | 1 serving prebiotic food (e.g., 1/2 onion or 1 banana) | Mild gas possible |
| 2 | 10g | 2 servings prebiotic foods or 1 food + supplement | Decreasing symptoms |
| 3 | 15g | 2-3 servings prebiotic foods | Adapted; symptoms resolve |
| 4 | 15-20g | 3+ servings prebiotic foods ± supplement | Full adaptation |
Key insight: A 2024 RCT found that both inulin and FOS significantly modulated gut microbiota composition after just 4 weeks, with FOS showing slightly superior effects on Bifidobacterium proliferation [15]. However, individual responses vary based on baseline microbiome composition.
Synbiotic Research
Synbiotics combine probiotics with prebiotics that specifically support those probiotic strains, creating a synergistic effect that outperforms either component alone. The ISAPP (International Scientific Association for Probiotics and Prebiotics) distinguishes between “complementary” synbiotics (probiotic + prebiotic with independent benefits) and “synergistic” synbiotics (prebiotic specifically selected to feed the included probiotic) [7].
How Synbiotics Work
- Improved probiotic survival — Prebiotics provide an immediate food source, helping probiotics establish in the gut
- Enhanced colonization — Prebiotics create a favorable environment (lower pH, competitive exclusion of pathogens)
- Greater SCFA production — Combined intervention produces more butyrate, acetate, and propionate than either alone
- Amplified immune modulation — Synergistic effects on gut barrier integrity and immune cell function
Clinical Evidence for Synbiotics
| Study Type | Population | Intervention | Key Finding | Reference |
|---|---|---|---|---|
| Meta-analysis (2024) | Older adults (60+) | PPS interventions | Synbiotics superior for microbiota composition and inflammatory markers vs probiotics alone | [7] |
| RCT (2023) | IBS patients | Multi-strain probiotic + FOS | Greater IBS symptom reduction vs probiotic alone (52% vs 38%) | [16] |
| Meta-analysis (2022) | Mixed populations | Synbiotic vs placebo | Significant reductions in BMI, fasting glucose, and CRP vs placebo | [17] |
| RCT (2021) | Post-antibiotic | L. rhamnosus GG + inulin | Faster microbiome recovery (2 weeks vs 4 weeks with probiotic alone) | [18] |
Recommended Synbiotic Combinations
| Probiotic Component | Prebiotic Component | Target Use | Rationale |
|---|---|---|---|
| Multi-strain (Lactobacillus + Bifidobacterium) | FOS 5-10g | General gut health | FOS selectively feeds both genera |
| L. rhamnosus GG | Inulin 5-10g | Post-antibiotic recovery | Inulin supports LGG colonization |
| B. longum + B. lactis | GOS 5-10g | Immune + mental health | GOS is strongly bifidogenic |
| S. boulardii + Multi-strain | FOS + resistant starch | Severe dysbiosis | Broad-spectrum restoration |
Quality Factors Checklist
The supplement industry is poorly regulated, and not all probiotic products deliver what they promise. A 2019 analysis found that 16% of tested probiotic products contained fewer CFU than labeled, and some contained strains not listed on the label [19]. Use this checklist to evaluate any probiotic supplement.
✅ Quality Assessment Checklist
- CFU guaranteed through expiration — Not manufacture date. A product listing “10 billion CFU at time of manufacture” may contain only 1-2 billion by expiration
- Full strain identification — Genus + species + strain (e.g., Lactobacillus rhamnosus GG). Avoid products listing only genus or genus+species without strain designation
- Third-party testing — USP, NSF International, or ConsumerLab verification of CFU viability, strain identity (DNA verified), and absence of contaminants
- Appropriate delivery system — Enteric-coated, delayed-release, or spore-forming for therapeutic use. Standard capsules are acceptable for maintenance only
- Clinical research — Specific strains in the product have published human clinical trials (not just the species)
- Proper storage instructions — Clear labeling: “Refrigerate after opening” or “Store in cool, dry place.” Absence of storage instructions is a red flag
- GMP certification — Manufactured in a Good Manufacturing Practices certified facility
- No unnecessary additives — Avoid products with excessive fillers, artificial colors, or allergens not relevant to the formulation
- Allergen transparency — Clear disclosure of dairy, soy, gluten, or other allergens (some strains are cultured on dairy)
- Expiration date — Adequate remaining shelf life at time of purchase (minimum 6 months)
Reputable Brands with Clinical Research
| Brand | Notable Products | Clinical Backing | Third-Party Tested |
|---|---|---|---|
| Culturelle | LGG-based formulas | 1,000+ published LGG studies | ✅ |
| Visbiome (formerly VSL#3) | High-potency multi-strain (450B-900B CFU) | Multiple RCTs for IBD and IBS | ✅ |
| Garden of Life | Dr. Formulated Probiotics | Brand-specific clinical trials | ✅ USP |
| Renew Life | Ultimate Flora line | Multiple strain-specific studies | ✅ |
| Jarrow Formulas | Jarro-Dophilus EPS | Enteric-coated delivery research | ✅ |
| Klaire Labs | Ther-Biotic line | Practitioner-grade, research-backed | ✅ NSF |
| Seed | DS-01 Daily Synbiotic | Published human clinical trials on specific formulation | ✅ |
When to Use Probiotics & Prebiotics
During and After Antibiotics
| Phase | Protocol | Key Details |
|---|---|---|
| During antibiotics | S. boulardii 5-10B CFU twice daily | Take simultaneously (yeast — unaffected by antibiotics) |
| During antibiotics | Bacterial probiotics 10-50B CFU | Separate from antibiotic dose by 2-3 hours |
| After antibiotics | Multi-strain 20-50B CFU + prebiotics 10g | Continue 2-4 weeks post-course |
| Long-term restoration | Multi-strain 10-20B CFU + prebiotic foods | Ongoing for 2-3 months after severe courses |
By Health Goal
| Goal | Probiotic Protocol | Prebiotic Protocol | Timeline |
|---|---|---|---|
| IBS management | L. plantarum 10-20B + B. infantis 10B daily | Start 5g, build to 10-15g (avoid excess with FODMAP sensitivity) | 8-12 weeks minimum |
| Immune support | L. rhamnosus GG + B. lactis 10-20B daily | 10-20g prebiotic foods daily | Seasonal or year-round |
| Mental health | B. longum 10-20B daily | 10-20g daily (supports gut-brain axis) | 8-12 weeks minimum |
| Travel | S. boulardii + L. rhamnosus GG 10-20B daily | Maintain usual prebiotic intake | Start 1 week before → during → 1 week after |
| Weight management | Multi-strain 10-20B daily | 15-20g daily (satiety + metabolic effects) | 12+ weeks |
| Skin health (acne/eczema) | L. rhamnosus GG + L. acidophilus 10-20B daily | 10-15g daily | 8-12 weeks |
Side Effects & Contraindications
Common Side Effects (Usually Temporary)
| Side Effect | Cause | Management | Expected Resolution |
|---|---|---|---|
| Bloating/gas (probiotics) | Microbial rebalancing | Start low (5-10B), increase gradually | 3-7 days |
| Bloating/gas (prebiotics) | Rapid fermentation | Start 5g, increase 5g per week | 1-2 weeks |
| Mild diarrhea | Microbiome shift | Reduce dose temporarily | 3-5 days |
| Constipation (rare) | Strain-dependent | Switch strains; add prebiotics | 1-2 weeks |
Contraindications — When to Consult a Doctor First
| Population | Risk | Action |
|---|---|---|
| Immunocompromised (HIV, chemotherapy, organ transplant) | Rare bacteremia/fungemia risk | Consult physician before starting |
| Critically ill / ICU | Risk of bloodstream infection | Avoid without medical supervision |
| Central venous catheter | Risk of line infection | Use with caution; consult physician |
| Severe acute pancreatitis | May worsen outcomes | Avoid |
| SIBO (prebiotics) | May worsen symptoms by feeding bacteria in wrong location | Start very low; consider low-FODMAP first |
| Severe IBS (prebiotics) | Initial worsening possible | Start 2-5g; increase very slowly |
Combining with Fermented Foods
Fermented foods provide natural probiotics, prebiotics, enzymes, and nutrients that supplements alone cannot replicate. A landmark 2021 Stanford study published in Cell found that a high-fermented-food diet (6+ servings/day for 10 weeks) significantly increased microbiome diversity and reduced inflammatory markers — effects not seen with a high-fiber diet alone [20].
Fermented Foods Database
| Food | Key Organisms | Serving Size | Probiotic CFU (approx.) | Additional Benefits |
|---|---|---|---|---|
| Kefir | 30-50 strains (bacteria + yeast) | 1 cup (240ml) | 10-20 billion | Most diverse probiotic food; contains B vitamins, K2 |
| Yogurt (live cultures) | L. bulgaricus, S. thermophilus ± added strains | 1 cup (245g) | 1-10 billion | Calcium, protein; look for “live and active cultures” seal |
| Sauerkraut (raw) | L. plantarum, L. brevis | 1/4 cup (35g) | 1-10 billion | Vitamin C, fiber; must be unpasteurized |
| Kimchi | L. plantarum, L. brevis, L. sakei | 1/4 cup (50g) | 1-10 billion | Vitamins A, C, K; capsaicin anti-inflammatory |
| Kombucha | Acetobacter, Gluconobacter, yeasts | 8 oz (240ml) | Variable | B vitamins, organic acids; watch sugar content |
| Miso | A. oryzae | 1 tbsp (17g) | Variable | Complete protein; enzymes; antioxidants |
| Tempeh | R. oligosporus | 3 oz (85g) | Variable | 15g protein per serving; B12 |
Best strategy: Combine 2-3 servings of diverse fermented foods daily with targeted probiotic supplementation. Rotate different fermented foods throughout the week for maximum strain diversity. The Stanford study suggests fermented food diversity matters more than quantity [20].
Curated Research Library
Key studies organized by topic and graded by evidence quality:
Probiotic Clinical Evidence
- [A] Szajewska, H. et al. “Probiotics for the Prevention of Antibiotic-Associated Diarrhea in Children.” J Pediatr Gastroenterol Nutr, 2016. PMC4769937
- [A] Ford, A.C. et al. “Efficacy of Prebiotics, Probiotics, and Synbiotics in Irritable Bowel Syndrome.” Am J Gastroenterol, 2018. PubMed 30066023
- [A] Hao, Q. et al. “Probiotics for preventing acute upper respiratory tract infections.” Cochrane Database Syst Rev, 2015. PubMed 25927096
- [A] Allen, A.P. et al. “Bifidobacterium longum 1714 as a translational psychobiotic.” Transl Psychiatry, 2016. PMC5143390
Prebiotic Research
- [A] Davani-Davari, D. et al. “Prebiotics: Definition, Types, Sources, Mechanisms, and Clinical Applications.” Foods, 2019. PMC6463098
- [A] Guarino, M.P.L. et al. “Mechanisms of Action of Prebiotics and Their Effects on Gastro-Intestinal Disorders.” Nutrients, 2020. PMC7400611
- [A] Saeed, M.A. et al. “Prebiotics and Gut Health: Mechanisms, Clinical Evidence, and Future Directions.” PMC, 2025. PMC12899272
Synbiotic Research
- [A] Nguyen, T.T.B. et al. “Effects of probiotics, prebiotics, and synbiotics on gut microbiota in older adults: a systematic review and meta-analysis.” PMC, 2025. PMC12482033
- [A] Pandey, K.R. et al. “Probiotics, prebiotics and synbiotics — a review.” J Food Sci Technol, 2015. PMC4648921
Microbiome & Fermented Foods
- [A] Wastyk, H.C. et al. “Gut-microbiota-targeted diets modulate human immune status.” Cell, 2021. PMC8370348
- [A] Valdes, A.M. et al. “Role of the gut microbiota in nutrition and health.” BMJ, 2018. PMC6000740
Gut-Brain Axis
- [A] Cryan, J.F. et al. “The Microbiota-Gut-Brain Axis.” Physiol Rev, 2019. PubMed 31460832
- [B] Akkasheh, G. et al. “Clinical and metabolic response to probiotic administration in patients with major depressive disorder.” Nutrition, 2016. PubMed 26706022
Delivery & Quality
- [B] Govender, M. et al. “A Review of the Advancements in Probiotic Delivery: Conventional vs. Non-conventional Formulations for Intestinal Flora Supplementation.” AAPS PharmSciTech, 2014. PMC3969478
📋 Free Tools
📋 Free Tools: Download our Probiotic Strain Selector & Dosing Tracker
→ Browse all free health tools on Notion
Contributing
Contributions are welcome! To add or update probiotic/prebiotic resources:
- Fork this repository
- Add entries following the format and evidence grading system above
- Include at minimum: evidence grade, strain specificity, CFU range, 1+ PubMed or DOI citation
- Submit a pull request with a brief description of your changes
Contribution Standards
- All claims must be backed by peer-reviewed research (Tier 1 or 2 sources preferred)
- Include the full citation in the References section
- Evidence grades must follow the grading system defined in the Evidence-Based Supplements Database
- Disclose any conflicts of interest
Disclaimer
This repository is for educational purposes only. The information provided does not constitute medical advice. Consult a qualified healthcare professional before starting any supplementation protocol, especially if you are immunocompromised, pregnant, nursing, or taking medications. Individual responses to probiotics and prebiotics vary based on baseline microbiome composition, health status, and other factors.
References
- Valdes, A.M. et al. “Role of the gut microbiota in nutrition and health.” BMJ, 2018. https://pmc.ncbi.nlm.nih.gov/articles/PMC6000740/
- Szajewska, H. et al. “Systematic review with meta-analysis: Lactobacillus rhamnosus GG for treating acute gastroenteritis in children.” Aliment Pharmacol Ther, 2019. https://pubmed.ncbi.nlm.nih.gov/31433527/
- Allen, A.P. et al. “Bifidobacterium longum 1714 as a translational psychobiotic.” Translational Psychiatry, 2016. https://pmc.ncbi.nlm.nih.gov/articles/PMC5143390/
- Szajewska, H. & Kolodziej, M. “Systematic review with meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea.” Aliment Pharmacol Ther, 2015. https://pubmed.ncbi.nlm.nih.gov/26216624/
- Ouwehand, A.C. “A review of dose-responses of probiotics in human studies.” Beneficial Microbes, 2017. https://pubmed.ncbi.nlm.nih.gov/28008787/
- Saeed, M.A. et al. “Prebiotics and Gut Health: Mechanisms, Clinical Evidence, and Future Directions.” PMC, 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12899272/
- Nguyen, T.T.B. et al. “Effects of probiotics, prebiotics, and synbiotics on gut microbiota in older adults: a systematic review and meta-analysis of randomized controlled trials.” PMC, 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12482033/
- Sanders, M.E. et al. “Probiotics and prebiotics in intestinal health and disease.” Nat Rev Gastroenterol Hepatol, 2019. https://pubmed.ncbi.nlm.nih.gov/31296969/
- Zuccotti, G. et al. “Probiotics for prevention of atopic diseases in infants: systematic review and meta-analysis.” Allergy, 2015. https://pubmed.ncbi.nlm.nih.gov/26198702/
- Ducrotté, P. et al. “Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome.” World J Gastroenterol, 2012. https://pubmed.ncbi.nlm.nih.gov/22969234/
- Grin, P.M. et al. “Lactobacillus for preventing recurrent urinary tract infections in women: meta-analysis.” Can J Urol, 2013. https://pubmed.ncbi.nlm.nih.gov/23930605/
- Hao, Q. et al. “Probiotics for preventing acute upper respiratory tract infections.” Cochrane Database Syst Rev, 2015. https://pubmed.ncbi.nlm.nih.gov/25927096/
- Govender, M. et al. “A Review of the Advancements in Probiotic Delivery: Conventional vs. Non-conventional Formulations.” AAPS PharmSciTech, 2014. https://pmc.ncbi.nlm.nih.gov/articles/PMC3969478/
- Malavolta, M. et al. “Bacillus coagulans: a viable adjunct therapy for relieving symptoms of IBS.” BMC Gastroenterol, 2020. https://pubmed.ncbi.nlm.nih.gov/32560623/
- Zhou, H. et al. “Differential effects of inulin and fructooligosaccharides on gut microbiota.” RCT, 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12219383/
- Ford, A.C. et al. “Efficacy of Prebiotics, Probiotics, and Synbiotics in Irritable Bowel Syndrome.” Am J Gastroenterol, 2018. https://pubmed.ncbi.nlm.nih.gov/30066023/
- Hadi, A. et al. “Effects of probiotics, prebiotics and synbiotics on anthropometric, cardiometabolic and inflammatory markers.” Clinical Nutrition, 2024. https://doi.org/10.1016/j.clnu.2024.05.015
- Pandey, K.R. et al. “Probiotics, prebiotics and synbiotics — a review.” J Food Sci Technol, 2015. https://pmc.ncbi.nlm.nih.gov/articles/PMC4648921/
- Labdoor. “Probiotic Rankings.” 2019. https://labdoor.com/rankings/probiotics
- Wastyk, H.C. et al. “Gut-microbiota-targeted diets modulate human immune status.” Cell, 2021. https://pmc.ncbi.nlm.nih.gov/articles/PMC8370348/
- Cryan, J.F. et al. “The Microbiota-Gut-Brain Axis.” Physiol Rev, 2019. https://pubmed.ncbi.nlm.nih.gov/31460832/
- Davani-Davari, D. et al. “Prebiotics: Definition, Types, Sources, Mechanisms, and Clinical Applications.” Foods, 2019. https://pmc.ncbi.nlm.nih.gov/articles/PMC6463098/
- Guarino, M.P.L. et al. “Mechanisms of Action of Prebiotics and Their Effects on Gastro-Intestinal Disorders.” Nutrients, 2020. https://pmc.ncbi.nlm.nih.gov/articles/PMC7400611/
- Akkasheh, G. et al. “Clinical and metabolic response to probiotic administration in patients with MDD.” Nutrition, 2016. https://pubmed.ncbi.nlm.nih.gov/26706022/
- Markowiak, P. & Slizewska, K. “Effects of Probiotics, Prebiotics, and Synbiotics on Human Health.” Nutrients, 2017. https://pmc.ncbi.nlm.nih.gov/articles/PMC5622781/
Further Reading
- HealthSecrets Probiotic & Prebiotic Complete Guide — Full deep-dive with product reviews and recommendations
- Evidence-Based Supplements Database — Comprehensive supplement evidence database
- Awesome Gut Health Resources — Curated gut health research and protocols
- Evidence-Based Prebiotic Foods Database — Detailed prebiotic food sources
- Evidence-Based Fermented Foods Resources — Fermentation recipes and probiotic food guide
- Evidence-Based Gut-Brain Axis Resources — Psychobiotic research database
- Immune Probiotic Strains Guide — Immune-focused probiotic strain comparisons
- Gut Immune Connection Resources — Gut-immune research database
- Anti-Inflammatory Gut Foods Database — Anti-inflammatory food research
- Evidence-Based Probiotics — Strain Database — Additional probiotic strain data
© HealthSecrets.com — Evidence-based health guides. For informational purposes only. Not medical advice.